COLL vs HON · P/E 17, rev $181.9M vs P/E 36, rev $9.72B
Collegium Pharmaceutical Inc (COLL) versus Honeywell International Inc (HON) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Honeywell International Inc (HON) is a conglomerates company listed on NASDAQ. It is led by Vimal Kapur.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported HON revenue for 2026-06-30 was $9.72B. Net income was $5.68B. Revenue was up 6.3% from 2026-03-31 to 2026-06-30. HON currently screens at market cap $144.86B and trailing P/E 36.5.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. HON currently screens at market cap $144.86B and trailing P/E 36.5.
Not investment advice. Open the COLL and HON stock pages for the full models.
Not investment advice.